Carna Biosciences, Inc. (TYO:4572)

Carna Biosciences Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,347	5,729	8,950	7,390	14,666	15,031
Market Cap Growth	-35.99%	-35.99%	21.11%	-49.61%	-2.43%	-38.91%
Enterprise Value	3,298	3,506	5,737	3,994	11,150	10,778
Last Close Price	280.00	300.00	522.00	520.00	1102.00	1212.00
PS Ratio	8.41	9.01	5.51	5.33	7.27	13.27
PB Ratio	2.16	2.32	2.31	2.03	3.40	3.93
P/TBV Ratio	2.16	2.32	2.31	2.03	3.40	3.93
EV/Sales Ratio	5.19	5.51	3.53	2.88	5.53	9.51
EV/FCF Ratio	-2.38	-	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.05	0.08	0.13	0.11
Asset Turnover	0.18	0.18	0.38	0.29	0.39	0.22
Inventory Turnover	1.16	1.16	1.36	1.50	1.26	1.89
Quick Ratio	9.89	9.89	9.81	8.17	6.54	6.09
Current Ratio	12.33	12.33	11.18	9.41	6.87	6.48
Return on Equity (ROE)	-68.60%	-68.60%	-30.65%	-33.92%	-13.13%	-28.94%
Return on Assets (ROA)	-36.44%	-36.44%	-16.21%	-16.37%	-6.46%	-12.94%
Return on Capital (ROIC)	-39.37%	-39.37%	-17.46%	-18.06%	-7.29%	-14.96%
Earnings Yield	-40.73%	-38.02%	-12.87%	-18.25%	-3.64%	-7.39%
FCF Yield	-25.94%	-24.21%	-18.86%	-11.29%	-10.75%	-8.81%
Buyback Yield / Dilution	-6.61%	-6.61%	-23.37%	-7.26%	-3.22%	-10.64%

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.